Biomarin Pharmaceutical (BMRN) Inventory (2016 - 2025)
Historic Inventory for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.
- Biomarin Pharmaceutical's Inventory rose 1719.9% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1719.9%. This contributed to the annual value of $1.2 billion for FY2024, which is 1133.24% up from last year.
- As of Q3 2025, Biomarin Pharmaceutical's Inventory stood at $1.4 billion, which was up 1719.9% from $1.3 billion recorded in Q2 2025.
- Biomarin Pharmaceutical's 5-year Inventory high stood at $1.4 billion for Q3 2025, and its period low was $711.0 million during Q2 2021.
- For the 5-year period, Biomarin Pharmaceutical's Inventory averaged around $1.0 billion, with its median value being $975.5 million (2023).
- In the last 5 years, Biomarin Pharmaceutical's Inventory crashed by 441.98% in 2021 and then surged by 2383.89% in 2024.
- Biomarin Pharmaceutical's Inventory (Quarter) stood at $776.7 million in 2021, then increased by 15.12% to $894.1 million in 2022, then increased by 23.83% to $1.1 billion in 2023, then grew by 11.33% to $1.2 billion in 2024, then increased by 12.13% to $1.4 billion in 2025.
- Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.